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Abstract
Background: Chlamydia spp. are believed to use a conserved virulence factor called type III secretion (T3S) to
facilitate the delivery of effector proteins from the bacterial pathogen to the host cell. Important early effector
proteins of the type III secretion system (T3SS) are a class of proteins called the translocators. The translocator
proteins insert into the host cell membrane to form a pore, allowing the injectisome to dock onto the host cell to
facilitate translocation of effectors. CopB is a predicted hydrophobic translocator protein within the chlamydial T3SS.
Results: In this study, we identified a novel interaction between the hydrophobic translocator, CopB, and the
putative filament protein, CdsF. Furthermore, we identified a conserved PxLxxP motif in CopB (amino acid residues
166–171), which is required for interaction with its cognate chaperone, LcrH_1. Using a synthetic peptide derived
from the chaperone binding motif of CopB, we were able to block the LcrH_1 interaction with either CopB or
CopD; this CopB peptide was capable of inhibiting C. pneumoniae infection of HeLa cells at micromolar
concentrations. An antibody raised against the N-terminus of CopB was able to inhibit C. pneumoniae infection of
HeLa cells.
Conclusion: The inhibition of the LcrH_1:CopB interaction with a cognate peptide and subsequent inhibition of
host cell infection provides strong evidence that T3S is an essential virulence factor for chlamydial infection and
pathogenesis. Together, these results support that CopB plays the role of a hydrophobic translocator.
Background
Chlamydia infections represent a significant disease bur-
den worldwide. C. trachomatis infection can lead to pelvic
inflammatory disease (PID), salpingitis, and infertility in
women and epididymitis and infertility among men [1].
Furthermore, Chlamydia pneumoniae is a respiratory
pathogen causing approximately 10 % of community
acquired pneumonia [2]. Additionally, C. pneumoniae
infections have been associated with asthma exacerbations,
cardiovascular disease, Multiple Sclerosis, and Alzheimer’s
[3–7]. Combined, C. pneumoniae and C. trachomatis repre-
sent a significant disease burden. An essential component
of Chlamydia’s survival is creating an environmental niche
that exhibits the necessary requirements for replication and
survival. Type III secretion (T3S) is a complex mechanism
utilized by important Gram-negative bacterial pathogens.
Salmonella, Shigella, Yersinia, Pseudomonas, and Chla-
mydia all contain the highly conserved type III secretion
system (T3SS) of approximately 20–30 proteins [8–11]. To
manipulate their host environment, these bacteria secrete
toxic effector proteins directly into their target cell. Func-
tionally, the whole apparatus can be referred to as an
injectisome; however, it consists of smaller functional
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components, which include the cytoplasmic C-ring, the
inner and outer membrane rings, the needle complex, and
needle-tip complex [8–10, 12]. Each of these components
display numerous essential protein-protein interactions.
Despite the identification and characterization of many pu-
tative T3S proteins, it remains unclear whether Chlamydia
truly has a functional T3SS, and whether it plays a role in
replication and survival given the absence of a robust
genetic manipulation system for gene knockouts [13].
Chlamydia spp. undergo a unique biphasic life-cycle
starting with an infectious, non-metabolically active
elementary body (EB) [14–16]. Upon attachment of the
EB to the host cell, there is a conformational change
within the host membrane that allows for invasion of
the EB into a membrane-derived vacuole termed an
inclusion [16]. Once inside the inclusion, an as of yet
unknown signal triggers differentiation of the EB into a
metabolically-active, non-infectious reticulate body (RB)
that divides through binary fission until late in the infec-
tion cycle [16]. The infectious EB will then leave either
through a packaged release mechanism, called extrusion,
or through cell lysis, to repeat the infection cycle [17–19].
Throughout this process the T3SS is belived to play an
essential role in pathogenicity [12].
The translocator proteins of the T3S system are believed
to be critical to the survival of Chlamydia, by forming a
pore in the host cell membrane to allow for translocation
of effector proteins from the bacterial cytosol to the host
cell cytoplasm [8–10]. Analysis of the chlamydial genome
suggests that there may be two sets of translocator proteins,
CopB and B2 and CopD and D2, both of which are located
in the same operon as a predicted class II chaperone [20].
To date, there has been limited characterization of the
translocator proteins from Chlamydia spp. Early work on
the translocator proteins in Chlamydia indicated that both
CopB and CopB2 can be secreted from Yersinia spp. in a
T3S-dependent manner and that Scc2 co-precipitated with
CopB from a C. trachomatis infected monolayer [21]. More
recently, localization experiments have shown that CopB
and CopB2, when ectopically expressed in HeLa cells,
associate with the cytoplasmic and inclusion membrane,
respectively [22]. Our laboratory has previously character-
ized the minor hydrophobic translocator (CopD) from
Chlamydia pneumoniae. We have shown that it associates
with T3S components and contains an essential PxLxxP
motif for interaction with its class II chaperone, LcrH_1
[23]. Although many hypotheses can be made regarding the
possible function of the translocator proteins based on
orthologous T3SS translocator proteins, there is limited in-
formation on the biochemical characterization of chlamyd-
ial translocator proteins owing to the inherent difficulties of
working Chlamydia spp.
In this report, we characterize the putative T3SS translo-
cator protein CopB of C. pneumonia, explore interactions
between CopB and other T3SS proteins, and characterize
the chaperone binding domain of CopB. In addition, we
generated a novel peptide mimetic that blocks the inter-
action between the translocators, CopB and CopD, and
their chaperone, LcrH_1, and showed that the peptide
mimetic prevents infection. We also identify a CopB
epitope which is immunogenic and elicits neutralizing
antibodies that block C. pneumoniae infection supporting
an essential role for CopB in the infection of host cells.
Methods
Cloning
T3SS genes were cloned via PCR using genomic DNA from
C. pneumoniae CWL029 [23]. Fragments of CopB, exclud-
ing the transmembrane domains, were cloned due to
toxicity of full length CopB in E. coli. Using the Gateway
cloning system (Invitrogen) the following genes were
cloned into the pDONR201 vector with attB-containing
primers (note: subscript denotes amino acid number):




P168AcopB1–200. Each of the pDONR201
vectors were then used in an LR reaction to transfer the
gene into expression vectors, pDEST17 (N-Terminal
6xHis-tag), pDEST15 (N-Terminal GST-tag) and pDEST-
HisMBP (N-Terminal 6xHis-Maltose Binding Protein-tag).
Prior to protein expression, all constructs were verified by
Sanger sequencing at the MOBIX laboratory (McMaster
University).
Protein expression and purification
All constructs were transformed into E. coli BL21 and
recombinant protein was expressed following induction
with Isopropyl β-D-thiogalactopyranoside (IPTG). Protein
expression and purification were performed as described
by Bulir et al. (2014), with the following modifications
[23]. Briefly, 6 L of LB containing 100 μg/mL ampicillin
was inoculated with 1:100 dilution of an overnight culture
and split equally into 6x 2 L flasks. The cultures were then
grown at 37 °C with shaking at 250 RPM until an optical
density of 0.500 at 600 nm was reached. Cultures were
induced with 0.2 mM IPTG and were left incubating at
room temperature, shaking at 250 RPM for 3 h.
Glutathione-S-transferase (GST) pull-down assay
Glutathione-S-transferase pull-down assays were performed
as described by Bulir et al. (2014) [23]. Briefly, GST-tagged
proteins were bound to 1 mL GST beads for one hour at
4 °C on a mixing platform. GST beads were centrifuged at
3000 x g for 5 min to remove the supernatant and then
blocked with blocking solution (5 % BSA in PBS + 0.1 %
TWEEN-20) overnight at 4 °C. Blocked beads (50–100 μL)
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were mixed with E. coli lysates containing overexpressed
His-tagged protein for one hour. For experiments involving
the blockade of interaction between GST- and His-tagged
constructs, the chemically synthesized peptide was incu-
bated with the bait construct for 1 h at 4 °C prior to the
addition of the overexpressed His-tagged E. coli lysate. The
beads were then centrifuged at 16,000 × g for 10 s, the
supernatant was removed, and the pellet was washed with
high salt wash buffer (500 mM KCl, 20 mM Tris–HCl
pH 7.0, 0.1 % Triton X-100). The washing procedure was
repeated seven times to ensure complete removal of adven-
titiously bound protein. For GST pull-downs involving
synthetically produced peptide, the peptides were used at a
concentration of 500 µM. The glutathione-agarose beads
were then resuspended in 75 μL of SDS-PAGE loading dye.
The samples were analysed by SDS-PAGE and Western
blot analysis using a mouse anti-His antibody (GenScript,
New Jersey).
Bioinformatics
Orthologous proteins to CopB were identified using
BLASTP (Basic Local Alignment Search Tool Protein)
and PSI-BLAST, excluding Chlamydiaceae family from
the search. CopB was analyzed using the TMpred soft-
ware tool to predict transmembrane domains, using a
minimum transmembrane window of 17 and maximum
of 33. Coiled-coil prediction software, COILS, was used
to predict the presence of coiled-coil domains within
CopB, using the MTIDK scoring matrices, and weighting
for positions a & d.
Antibody and peptide inhibition of C. pneumoniae
infection in HeLa cells
Infection was performed as previously described by
Johnson et al. [15]. At approximately 72 h post infection,
chlamydial inclusions were stained with the Pathfinder
Chlamydia detection reagent (BioRad) and visualized with
multiple, random fields of view. Percent reduction of in-
fection was calculated compared to a control infection,
and statistical significance was calculated using a Student’s
t-test. A polyclonal antibody raised against a 15 amino
acid peptide (SGKDKTSSTTKTETC) from CopB was ob-
tained from GenScript (New Jersey). C. pneumoniae was
pre-incubated for 2 h at 37 °C with dilutions of affinity
purified CopB antibody, control antibody (anti-GST), or
pre-immunization sera. Additionally, chlamydial infection
inhibition was performed using a synthetic peptide (500
uM), vehicle alone (PBS), or control peptide (anti-RSV
peptide). Briefly, 5×105 IFUs were incubated with the
peptide or vehicle alone (PBS) for 2 h at 37 °C prior to
performing a standard infection and inclusions were
visualized as previously described.
Results
Bioinformatic analysis of Chlamydia outer protein (Cop) B
Translocator proteins have a conserved function across
numerous bacterial species, facilitating the translocation of
effector proteins from the bacterial cytosol to the host cell
cytoplasm through formation of pores within the host cell
membrane. However, there is limited sequence orthology
between Chlamydia spp. translocators and other well-
characterized bacterial translocator proteins. BLAST-P
analysis identified potentially orthologous sequences in the
recently sequenced genome of Bacteroides fragilis with an
expect value of 6e−141 and percent identity of 54 %. CopB is
a 493 amino acid protein with a predicted molecular weight
of 50.5 kDa. Potential transmembrane domains were identi-
fied using online prediction software, TMpred, which
suggests the presence of two transmembrane domains,
spanning amino acids 256–274 and 383–406, respectively,
and a hydrophobic stretch of amino acids from 180 to 200.
COILS software identified three potential coiled-coil
domains located at amino acids 117–140, 234–347, and
410–437. Sequence analysis of the N-terminal region of
CopB identified a conserved chaperone binding motif of
PxLxxP at amino acids 166–171 with the sequence of
PELPKP (Fig. 1). Together, these results are consistent
with features characteristically found in T3S translocator
proteins [22, 23].
CopB interacts with the putative needle filament protein,
CdsF
CopB is believed to be a T3S protein, and thus it should
interact with other proteins within the T3SS [10]. Cloning
fragments of CopB lacking the transmembrane domains
allowed us to identify specific domains of CopB that are
responsible for interactions with other type III secretion
components. GST pulldowns were performed between
CopB and Cpn0803, CdsF, and CopN. No interactions were
observed between any fragments of CopB and Cpn0803 or
CopN (Fig. 2a and b). There was a positive interaction
between the N-terminal (amino acids 1–255) and middle
fragment of CopB and CdsF, but not the C-terminus of
CopB (Fig. 2c). These observations are consistent with a
role in the T3S apparatus of Chlamydia pneumonia, since
translocator proteins from orthologous systems have been
shown to interact with the needle filament protein.
LcrH_1 interacts within the N-terminus of CopB
Cpn0811 (LcrH_1) is a small, basic isoelectric protein
located upstream in the same operon as CopB (Cpn0809)
[20]. We explored the possible interaction between
LcrH_1 and CopB and found that His-LcrH_1 interacts
within the N-terminus of CopB (Fig. 3a). Both CopB1–200
and CopB1–255 interacted with His-LcrH_1, but CopB1–180
did not, suggesting the hydrophobic stretch of amino acids
spanning residues 180–200 plays an important role in this
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interaction. Since CopB1–200 was the smallest truncation
construct that maintained an interaction with His-
LcrH_1, we examined the amino acid sequence for the
presence of a conserved chaperone binding motif, PxLxxP,
which begins at amino acid 166. To elucidate the import-
ance of the conserved motif, we performed an alanine
walkthrough of the conserved amino acids in the PxLxxP
motif starting at amino acid 166(P166ACopB1–200,
L168ACopB1–200,
P171ACopB1–200). Mutation of the PxLxxP
motif abrogated the interaction between His-LcrH_1 and
CopB (Fig. 3b). To ensure that the absence of interaction
was the result of the specific amino acid substitution, as
opposed to gross misfolding of the mutant protein,
L168ACopB1–200 was subjected to a GST pulldown against
CdsF. As expected, L168ACopB1–200 maintained the inter-
action with HisMBP-CdsF (Fig. 3c), suggesting that the
PxLxxP is a critical interaction domain between the
chaperone and CopB.
A CopB peptide mimetic blocks the LcrH_1 and CopB
interaction
Given the necessity of the PxLxxP motif for the interaction
between translocator proteins and their class II chaperones,
a synthetic peptide containing the chaperone binding motif
was synthesized and tested for its ability to block the
interaction between LcrH_1 and both CopB and CopD. To
determine whether a synthetic peptide consisting of a
cell penetrating peptide sequence (YGRKKRRQRRR) and
the 10 amino acids (ETPELPKPGV) encompassing the
chaperone binding motif of CopB is capable of preventing
the chaperone:translocator interaction, the peptide was
incubated with GST-CopB1–200 or GST-CopD1–157 prior
to the addition of His-LcrH_1. In the presence of the pep-
tide, no interaction was observed between the putative
Fig. 1 Genetic organization and topographic overview of structural prediction of CopB. Solid black regions represent transmembrane domains.
(a) Genetic organization of the ORF containing the putative translocator, CopB and CopD, and the TPR-domain containing chaperone, LcrH_1.
(b) Diagonal stripes represent predicted coiled-coil domain in the C-terminus of the protein. Vertical stripes depict predicted Chaperone Binding
Domain (CBD) spanning amino acid residues 168–171. The hydrophobic region is shown from amino acids 180–200
Fig. 2 Chlamydia Outer Protein (Cop) B Interacts with T3S proteins.
(a) GST-CopB1–255 or GST-CopB275–385 bound to glutathione-agarose
beads (bait) pulled HisMBP-CdsF (prey) out of an E. coli lysate in the
presence of a high salt wash buffer (500 mM NaCl). (b & c) Furthermore,
GST-CopB fragments did not pull His-CopN or Cpn0803 out of an
E. coli lysate in the presence of a high salt wash buffer
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translocators, CopB and CopD, and LcrH_1 under high salt
conditions (Fig. 4a). To explore the hypothesis that the
CopB:LcrH_1 and CopD:LcrH_1 interaction are essential
for infection, we then tested the ability of the peptide to
block C. pneumoniae infection. We pre-incubated C.
pneumoniae with the peptide or vehicle alone and then
infected host cells. The peptide inhibited infection by 90 %
compared to the control infection with vehicle alone
(Fig. 4b).
Anti-CopB antibody inhibits C. pneumoniae
Since T3S translocators are believed to be surface exposed
proteins in other T3SS, we hypothesized that antibodies
to CopB would inhibit infection [24–26]. We generated an
antibody to a peptide (15-mer) in the N-terminal region of
CopB and tested its ability to inhibit C. pneumoniae infec-
tion. To test whether this antibody could inhibit infection,
we pre-incubated C. pneumoniae with the polyclonal anti-
body for 1 h at 37 °C prior to infection. C. pneumoniae
infection was inhibited by the CopB antibody. (Fig. 5a-d),
resulting in a 98 % reduction in inclusion forming units,
as compared to control antibody (Fig. 5e). Using a
Western blot, polyclonal antibodies were able to detect
both recombinant and native CopB (Fig. 5f). The ability of
the CopB antibody to block infection suggests that CopB
is surfaced exposed, and plays a critical role in the infec-
tion process.
Discussion
Despite our increasing understanding of the T3SS in
Chlamydia spp., there is limited or no evidence for a
direct role for the translocator proteins during infection.
Our laboratory has previously characterized the putative
minor hydrophobic translocator, CopD, showing that it
plays an essential role during chlamydial infection [23].
In this report, we provide an initial characterization of
the major hydrophobic translocator, CopB. The inter-
action of CopB with the filament protein CdsF suggests
that it plays an essential role in T3S. As seen with other
translocator proteins, the putative chaperone located
immediately upstream of CopB interacted with the first
N-terminal 200 amino acids of CopB. Using an alanine
walkthrough of the conserved PxLxxP motif, we show
that amino acids P166, L168, and P171, in addition to
amino acids 180–200, are required for the interaction
between CopB and its’ cognate chaperone LcrH_1. We
demonstrated that a cognate CopB peptide encompass-
ing the chaperone binding motif can block the inter-
action between LcrH_1 and both CopB and CopD,
suggesting that the CBD is a critical binding domain.
Furthermore, we show that this peptide when pre-
Fig. 3 LcrH_1 (Cpn0811) interacts with CopB. (a) Recombinant LcrH_1 interacted with amino acids 1–200 of CopB. CopB mutants were created
using Gblock synthesis: P166ACopB1–200,
L168ACopB1–200, and
P171ACopD1–200. (b & c) Mutations at the conserved amino acids within the predicted
chaperone binding domain disrupted the interaction between CopB1–200 and the chaperone LcrH_1, but not other identified interactions
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Fig. 5 Inhibition of Chlamydia pneumoniae with CopB antibodies. Panels a-d show inhibition assay results performed with either no antibody (a),
CopB antibody (b), pre-immune sera (c), or control antibody (α-GST) (d). Panel e shows the degree of inhibition by of CopB antibodies compared
to control antibodies. Chlamydial inclusions are stained green, while HeLa cells are stained red by Evan’s blue counterstain. Panel f demonstrates
reactivity of anti-CopB with (1) C. pneumoniae infected HeLa cell lysate, (2) uninfected HeLa cell lysate, (3) recombinant GST-CopB1–255 produced
in E. coli, and (4) recombinant GST produced in E. coli. Experiments were performed in triplicate. Error bars represent 2 standard deviations. Images
represent random fields of view. * = P < 0.0001
Fig. 4 Peptide inhibition of the translocator:chaperone interaction. (a) Recombinant GST-CopD1–157 or GST-CopB1–200 was pre-incubated with
500 μM of the chaperone binding domain peptide mimetic (+) or vehicle alone (−). CopD1–157 and GST-CopB1–200 did not interact with its putative
chaperone in the presence of the CBD peptide, but did so in the presence of a control peptide or vehicle alone. (b) Left image is C. pneumoniae
incubated with vehicle alone (PBS), right image is C. pneumoniae incubated with 500 μM CBD Peptide, bottom image is C. pneumonia incubated
with 50 uM anti-RSV peptide. Chlamydial inclusions are stained green, while HeLa cells are stained red by Evan’s blue counterstain
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incubated with C. pneumoniae, blocked infection. To-
gether, these results strongly suggest that the PxLxxP
motif is required for the translocator-chaperone inter-
action, and for infection. We also show that a polyclonal
antibody raised against an N-terminal epitope within
CopB significantly reduced infection. Collectively, these
results are consistent with CopB’s role as a translocator
within the Chlamydia T3SS.
Initial bioinformatic studies were performed to gain
insight into the role of CopB in C. pneumoniae [21–23].
Chellas-Géry et al. identified potential hydrophobic and
coiled-coil domains within CopB from C. trachomatis [22].
Given the moderate level of sequence identity between C.
trachomatis and C. pneumoniae CopB (approximately 52 %
amino acid identity), a thorough bioinformatics analysis of
CopB was performed. BLASTP analysis of CopB yielded
one significant result from Bacteroides fragilis, typically a
commensal bacterium found in the gastrointestinal tract,
but no matches were found for other T3S systems, suggest-
ing that the C. pneumoniae T3SS may be quite unique
among orthologous systems, which is in keeping with
Chlamydiae containing an ancient T3SS. Although no
orthologous sequences of the chlamydial translocator pro-
teins were identified in the archetypal secretion systems
using our bioinformatics approach, the proteins are
predicted to have similar structure and function. Since
CopB is likely anchored within the host-cell cytoplasm to
facilitate translocation of effector proteins, we utilized
TMpred online software to identify potential transmem-
brane regions. Our analysis identified two potential trans-
membrane domains spanning amino acids 256–274 and
383–406, respectively. This is consistent with other translo-
cator proteins possessing two transmembrane domains to
anchor themselves within the host cell membrane [27, 28].
Using the COILS online prediction software, we identified
three potential coiled-coil domains, which may be import-
ant for mediating protein-protein or protein-membrane
interactions. The N-terminus of CopB contains a conserved
PxLxxP motif, followed by a sequence of hydrophobic
amino acids, which is seen in other translocator proteins
from C. pneumonia, and has been shown to be important
for mediating the essential translcoator:chaperone inter-
action in other bacterial systems (Shigella, Yersinia,
Salmonella) [23].
Due to the difficulty in genetically manipulating
Chlamydia and the inherent challenges of establishing
structure-function relationships for T3S proteins of obli-
gate intracellular pathogens dependent on T3S for infec-
tion, it is difficult to ascertain the role of chlamydial
T3SS proteins. We therefore explored the possible inter-
action between CopB and other proteins within the
chlamydial T3SS. The needle filament protein, CdsF in
Chlamydia, is believed to polymerize forming needle
structure for the translocation of effector proteins. The
translocator proteins are believed to be docked on the
tip of the injectisome to form the needle-tip complex,
prior to host cell contact. Two domains of CopB, amino
acids 1–255 and 275–382, interacted with CdsF using a
GST-pulldown assay. CopN, the putative plug protein, is
believed to be localized to the base of the needle appar-
atus and prevents premature secretion of effector pro-
teins. No apparent interaction between CopN and CopB
was observed using a GST-pulldown assay. Although an
interaction was observed between CopD and CopN, the
lack of interaction between CopB and CopN suggests
that CopB may be secreted through the apparatus and
docked on the end of the needle complex before CopN
plugs the needle apparatus. Considering the fact that
recent work has suggested that Cpn0803 may be a
chaperone protein given its biophysical properties and
putative interactions, it is not surprising that CopB failed
to interact with Cpn0803 [29, 30]. The interaction
between CopB and the needle filament protein, CdsF, in
this report is a novel observation not previously reported
in the literature. It has been reported that the transloca-
tors are recruited to the tip of the needle complex either
upon detecting host cell contact or under secretion
conditions. Once the translocators are inserted into the
host cell membrane, the filament protein must anchor to
the host cell via the translocator proteins, which are now
imbedded in the host membrane. This result is consist-
ent with the role of the hydrophobic translocator
proteins in other T3SS since the needle protein must
interact with the translocator proteins on the host cell to
facilitate translocation of effector proteins [31, 32].
Interactions between class II chaperones and transloca-
tor proteins have been documented in Chlamydiae spp.
previously. Initial identification of the LcrH_1 and CopB
interaction, from C. trachomatis, was performed by Fields
et al. (2005) [10, 21]. Using a GST pulldown, we demon-
strated that the N-terminus of CopB1–255 interacts with
LcrH_1, which is in keeping with LcrH_1 orthologs inter-
acting within the N-terminus of translocator proteins
[28, 33]. An additional truncation series showed that the
removal of the hydrophobic amino acids from 180 to 200
eliminated the interaction of LcrH_1 and CopB despite
the presence of the PxLxxP motif within the CopB1–180
construct. The PxLxxP motif is conserved in members of
the Chlamydiaceae family, despite the low amino acid
sequence identity, suggestive of an important role for the
chaperone binding motif (Table 1). An alanine walk-
through of the conserved amino acids in the PxLxxP motif
disrupted the interaction between CopB1–200 and LcrH_1.
Our data indicates that the interaction between CopB and
LcrH_1 is dependent on both the PxLxxP motif and the
CopB180–200 domains.
The co-crystal structure of class II chaperones (LcrH_1
orthologs) with the translocator PxLxxP domain confirms
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the interaction between the two proteins [28]. Based on
this interaction we hypothesized that a cognate peptide of
CopB containing the PxLxxP peptide sequence could
disrupt the translocator-chaperone interaction. We there-
fore tested a peptide containing the 10 amino acids
encompassing the PxLxxP domain plus a cell penetrating
peptide sequence to test this hypothesis. Since the PxLxxP
motif is conserved between CopB and CopD, we pre-
incubated LcrH_1 with the cognate peptide then added
either CopB or CopD fragments to the GST pull down
and showed that the peptide blocked the interaction
between LcrH_1, and CopB and CopD. Since the cell
penetrating peptide sequence allows proteins to enter
cells, we hypothesized that this cognate peptide would
block chlamydial infection and intracellular replication
[34, 35]. After pre-treating C. pneumoniae with this pep-
tide, we observed a significant reduction of 90 %, com-
pared to control infection, with vehicle alone. Since it is
currently not possible to create genetic knockouts in
Chlamydia, peptide mimetics could be used to create
functional knockouts to study the resultant phenotype.
The peptides ability to significantly reduce infection rein-
forces the importance of the chaperone binding motif for
the chaperone-translocator interaction and may represent
a novel target for therapeutic intervention using peptide
mimetics.
Conclusions
Antibodies to the translocator proteins in orthologous
secretion systems have been shown to inhibit infection,
suggesting that the translocator proteins play an essen-
tial role during infection [36–40]. Using antibodies
raised to an N-terminal epitope of CopB, we demon-
strated that anti-CopB antibodies inhibited C. pneumoniae
infection by 98 %. Inhibition of infection by anti-CopB
antibodies indicates that CopB is surface exposed at some
time during infection and play an essential role in infec-
tion. Given the fact that CopB is surface exposed during
the initial phase of chlamydial infection, the translocator
proteins may represent a novel class of antigens for use in
vaccination strategies to prevent chlamydial infections.
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